The nonspecific clinical feature of NAFLD is elevated hepatic aminotransferase (ALT and AST) and they are positively correlated with most patients with NAFLD (Bacon et al., 1994). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.